Evidence Hub

Utility of bone densitometry in diagnostic evaluation and monitoring in regional migratory osteoporosis

Cadet M, Honig S

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2009

Abstract

Regional migratory osteoporosis (RMO) is a rare, self-limited disease of unknown etiology, characterized by migratory arthralgia of the weight-bearing joints of the lower extremities. RMO is most commonly seen in middle-aged adults, particularly men. Several case reports suggest that bone changes seen in RMO may be detected as focal decreases in bone mineralization, but the utility of serial bone density studies has yet to be formally evaluated in this syndrome. We describe a case of RMO with dramatic focal changes in bone mineral density that corresponded to the underlying clinical course. Serial bone density testing clearly documented significant bone loss and subsequent recovery of bone density in areas affected by RMO. Our data suggest that sequential densitometric examination of affected areas may be useful to confirm the diagnosis of RMO, and for subsequent monitoring of bone loss and therapeutic response.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free